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Abstract Chloride is critical in creating differential pH
values inside various organelles (Golgi for example) by
linking ATP hydrolysis to trans-bilayer proton movement.
This proton-ATPase drives anions such as chloride through
unrelated channels in the endosomal/organellar bilayer
thus loading HCl into different lipid-encased cellular
compartments. Critically, intraorganellar pH (and ion
channel content/activities) differs during different phases
of the cell cycle. The cystic ﬁbrosis (CF) chloride channel
protein CFTR is a member of the ABC family (ABCC7)
and resides in many endosomal membranes trafﬁcking to
the epithelial surface and back again. Recently, it has
become clear that human CF has an unusually high inci-
dence of cancer in the bowel with correspondingly elevated
gut epithelial proliferation rates observed in CF mice. In
this review, emphasis is placed on CK2 & CF because CK2
controls not only proliferation but also four different
members of the ABC superfamily including the multi-drug
resistance protein P-glycoprotein and CFTR itself. In
addition, CK2 also regulates a critical cancer-relevant and
CFTR-regulated cation channel (ENaC) that mediates the
cellular accumulation of sodium ions within epithelia such
as the colon and lung. Not only are ENaC and CFTR both
abnormal in CF cells, but ENaC also ‘carries’ CK2 to the
cell membrane in oocytes, only provided its two target
phosphosites are intact. CK2 may be a critical regulator of
cell proliferation in conjunction with regulation of ion
channels such as CFTR, other ABC members and the
cation channel ENaC. The emerging idea is that CFTR may
control membrane-CK2 as much as membrane-CK2
controls CFTR.
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Abbreviations
CFTR Cystic ﬁbrosis transmembrane conductance
regulator
ABC ATP-binding cassette
PD Potential difference
ENaC Epithelial sodium channel
NBD Nucleotide binding domain
Introduction
Epithelia balance two conﬂicting roles, namely, keeping
the organism’s outside-world out and the inside-world
in, whilst maintaining the facility to secrete and absorb
across the epithelial barrier. This epithelial layer may be
a single sheet of cells or multi-stacked (interlinked by
hemi-desmosomes to a stem cell layer) but in all cases, the
distal membrane of the outermost cell faces the milieu
surrounding the organism. It is commonly found that
electrodes placed on an epithelial surface, when connected
to another in the blood, register a few millivolts difference
on a voltmeter. This review links that ﬁnding to a protein
kinase involved in cancer biology. The essential protein
kinase (CK2, formerly known as casein kinase 2) has been
implicated in multiple steps in neoplasia. As a ﬁrst step
towards linking this ﬁnding to an ion channel, emerging
data are discussed suggesting that CK2 can control
different members of the ATP-binding cassette (ABC)
superfamily and one of their interacting cation channels.
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Epithelia are polarised, but in two completely different
‘vectorial’ (directional) contexts.
• Firstly, the lipid and protein composition of the cell
membrane that faces the outer world (the apical
membrane, typically 25 square microns or about 6%
of the total cell surface area) differs from the majority
inward-facing membrane in contact with the inter-
cellular matrix (basolateral membrane). Differences in
lipid composition may be relevant for the relationship
between CK2 function and endocytosis in such mem-
branes (discussed below).
• Further, the surface area of both apical and basolateral
membranes in each epithelial cell (in a fully grown
organism) is held relatively constant by balancing lipid
and protein synthesis (that underpins new membrane
arrival from the Golgi-generated budding vesicles) with
the reverse process of membrane retrieval due to
endocytosis—critically, ion channels are involved in
such vesicle cycling and vesicle pH. Any change in cell
area will modulate cell volume, of necessity.
• Epithelial cell number is also held constant by balanc-
ing stem cell turnover in the lower, blood facing layers
with subsequent differentiation and directional cell
migration towards the surface of the epithelium. This
balances programmed cell death where once again, as
described below, different ion channels are critically
important. Cancers occur in such epithelia when the
controllers of cellular renewal and cell death become
disordered in a sequential process. Thus a polyp may be
considered as a ‘buckled’ epithelium.
• The second type of polarity is electrical and arises from
the differential membrane potentials generated across
these apical and basolateral membranes; a potential
arises from a net charge difference across a space
creating a force felt by all charged particles, should
opposite charges not be able to move towards each other
to cancel the force, a potential difference (PD) is said to
exist. Each apical and basolateral bilayer maintains a PD
that is set at its own resting level by virtue of its protein
content. This PD is created by the free diffusion of
charged potassium (but not other) ions through highly
ion-selective channel proteins which themselves differ
in each membrane. Both apical and basolateral PDs are
‘negative inside’ at rest and set by the (in to out) leakage
of positively charged potassium ions whose concentra-
tion inside the cells is 30-fold in excess of that found
outside (140 and 4.5 mM, respectively). Potassium is
topped up by the sodium potassium ATPase which can
consume 40% of cell energy even at rest. Thus highly
regulated K
+ exit creates a relative inner negativity as
K
+ diffuses down its concentration gradient through any
transiently open K
+-selective pore. Multiple such pores
exist, all regulated differently. Discussion focuses in
this paper on changing the expression of a type of K
+-
channel for example to a calcium-activated or ATP-
gated K
+ channel which has been proposed as a
controller of the cell cycle.
• The different PD-magnitude across two membranes in
the same epithelial cell can occur simultaneously
because of electrically resistant protein moieties at the
Zona Occludens (ZO). This apical–apical insulating
junction between two epithelial cells is often called a
tight junction and ‘spot-welds’ the most lateral ends of
adjacent apical membranes to one other. In reality, such
junctions are variably leaky and plastic but this is
beyond the scope of the article but nevertheless, this
leads to the idea of a resistance to ﬂow of current across
an epithelium either across individual cells or between
cells as a trans-epithelium PD relative to the blood.
• To bridge the interface between cancer biology and
electrophysiology, a key technical limitation has to be
considered that affects interpretation of the data.
Protein serum factors may be excluded from normal
(but not cancer-breached) epithelia by compartments
such as the basal lamina that normally separates the
basal cells in an epithelium from the underlying
capillaries/blood stream. The technical difﬁculty is that
serum factors are present in cell culture but not in vivo.
The result is that epithelial cells often show different
ion channel characteristics when compared in serum to
the balanced salt solutions favoured by electrophysiol-
ogists during their ion channel studies. For example, a
rapidly turning over ion channel may disappear when
placed in balanced salts.
Results
Cancer and ion channels: a new frontier
Electrophysiology and cancer cell biology do not always
make good bed fellows. To paraphrase one prominent
cancer researcher, ‘whenever we came across an ion
channel as a cancer gene, we ignored it, not really knowing
what question to ask let alone, answer’. Two reviews were
published in 2005 that bridge that gap [1, 2]. For example,
Kunzelmann [2], who began as an electrophysiologist but
has widened his research into tumour biology [3], states
that you cannot apoptose without shrinking cell volume.
To an electrophysiologist this means you need at least a
potassium channel with a high throughput of ions per
second (high conductance, the inverse of resistance) to
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123drive cell-shrinkage but typical value of 40 mM intracel-
lular chloride must co-exit by its own anion-selective
channels to maintain charge neutrality. Water follows. The
cell shrinks. This process, when defective, has been
recently linked to cancer cell drug resistance [4]. Further,
Kunzelmann points out [2] that the menu of available K
+-
channels differs in different parts of the cell cycle. For
example, when cell volume needs to be stable (‘BK’
channels found mainly in S phase are present) or when
membrane voltage needs to be in a special range, inter-
mediate conductance (IC) K
+ channels in G1 phase create
a bigger negative-inside potential to ‘attract in’ ionised
calcium; cytosolic calcium is characteristically elevated at
this time from the low nanomolar to the micromolar range;
outside cells and inside some organelles, calcium is milli-
molar. Further still, to exit G1, another type of K
+-channel
may be needed (a K
+-ATP gated channel). Overall this
suggests that co-ordinated, energy-regulated, sequential
expression of different channels at different times is
somehow linked to cell volume, cell death and cell division
[1, 2]. In summary, the working hypothesis is that any cell
will have basal homeostatic roles fulﬁlled by multiple ion
channels, but will need to induce/regulate a different set of
channels or proliferation/senescence will not occur in
normal sequence [3]. It follows that a cell that fails to
express the right type of channels for apoptosis may be
unable to perform this action.
Such K
+-channels do not act alone
They coordinate their activities with chloride/anion
movement to drive changes in cellular/organellar ion
composition and hence cell/organellar volume (often called
regulatory cell volume increase, RVI or decrease RVD).
Chloride is an abundant mobile intracellular anion, unlike a
(negatively charged) cell cytosol protein, say. This volume
recovery process goes awry in CF cells as found by the
elegant work of Valverde and co-workers many years ago
[5] and is now linked to cancer [4]. The presence of cell
membrane proteins generates 90% of trans-bilayer water
movement which otherwise has a very low permeability
across bilayer lipids [6]. Chloride permeability is low in
G0 and rises through G1 to S phase with corresponding
changes in chloride channel protein expression and func-
tion. K
+-channels also change co-temperaneously but the
signals creating the links are complex involving ion con-
centration and phosphorylation [1, 2, 6–8].
In relation to membrane PD, it is correspondingly
observed that in G0, PD is very negative (yet chloride does
not move out—see above—suggesting tight regulation) but
becomes much less negative in proliferative phases (and
cancer cell lines). The movement of protons/hydroxyl ions
across lipid bilayers is also involved. Thereby, cytosolic
pH changes during these phase transitions become more
alkaline in G1/S transition, for example. The processes
interlinked with this decrease in intracellular pH (hydroxyl
exit or proton entry) correlate with a rise in intracellular
calcium and changes in pH sensing mediated by the cal-
cium and phospholipid binding annexin family [7]. Others
ﬁnd regulatory and binding links between annexins and the
function of chloride channels such as CFTR [8].
Membrane proteins, cancer, cystic ﬁbrosis and CK2
function
A focus is now placed on a proposed latent role for the
cystic ﬁbrosis transmembrane conductance regulator
(CFTR) and CK2 with a cation channel, ENaC (Epithelial
Na
+ Channel) as an example of an ion channel cancer link.
Without treatment, *90% of cystic ﬁbrosis (CF) babies die
within the ﬁrst 2 years of life with uncontrolled exocrine
pancreatic failure, a consequent inability to gain weight
whilst developing pneumonia with unusual gram positive
and gram negative organisms. CF is a mucosal-damaging,
autosomal recessive disorder [9] resulting from many
mutations in CFTR (ABCC7), an apically located and
largely epithelial member of the ABC (ATP-Binding Cas-
sette) superfamily of proteins (but with signiﬁcant low
level expression outside epithelia, including, variably
cancer cell lines such as Hela cells). Wild-type CFTR
normally contains 1,480 amino acids but alternative splice
forms are known, particularly in fetal life, when CFTR is
most heavily expressed and especially during rapid epi-
thelial cell proliferation [10]. CFTR is also expressed in red
cells, macrophages, bone, etc., but generally, its expression
levels in adult tissue are very low or unknown and its
functions are relatively obscure outside epithelia [11]. One
copy of the defective CFTR gene is carried by as many as 1
in 17 Irish and 1 in 25–50 apparently healthy, predomi-
nantly white Europeans suggesting some ancient biological
advantage [9]. However, carriage of two CFTR mutations
prematurely terminates the lives of 1 in every 2,000–4,000
young adults of European descent (but CF is much rarer in
the Far East and almost unknown in Japan *1 in a million
births; recently reviewed by Walters and Mehta [9]).
Today in the developed world, such is the improvement
in childhood nutrition and potent drug treatment for CF-
induced gut and lung disease that CF adults almost out-
number CF children (see report in www.cystic-ﬁbrosis.
org.uk, accessed 05/08/2008). In teenage and older CF
patients (typically 30–50 years of age), this disease is
associated with an excess incidence of cancer [12]. The
data suggest that the most signiﬁcant association is for gut
cancer (5–13-fold excess relative risk in the third and
fourth decades of CF life). Yet, it has to be remembered
that such a CF patient has had life-long inﬂammation in
Mol Cell Biochem (2008) 316:169–175 171
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the gut epithelium, even in childhood [12]. The reasons are
unknown but the CF gut (unlike the lung) is exposed to
high fat and exogenously administered pancreatic enzymes.
The gut phenotype in CF begins in early fetal life but is of
variable severity involving antenatal gut atresia only in
about 15% of CF neonates [9]. It may be that the fetal gut is
intrinsically abnormal (i.e. even without atresia) as Ferec
and co-workers [13] report a period in early CF fetal life
when CFTR expression is undetectable for about three
weeks for the commonest form of CF. The signiﬁcance is
unknown. But it is clear that the maximum expression is at
around 16–24 weeks in the developing lung which shares
lineage with the gut [13]. This notion of intrinsic abnor-
mality is consistent with the ﬁndings of Gallagher and
Gottlieb who report an abnormally high gut epithelial
proliferation rate when cystic ﬁbrosis (CF) mice are null
for the murine CF gene product [14]. This concept of a role
for CFTR in fetal gut cell proliferation has received inde-
pendent support [15]. As CF patients become older
(survivors in their sixties are not uncommon), it may be
important to monitor their lung cancer risk.
ABC proteins, CFTR and CK2
In patch-clamp studies from wild-type epithelial cells,
cAMP-elevation (for example, with forskolin) induces
protein kinase A (PKA)-activation which immediately
stimulates rapid CFTR ﬂickering (passage of chloride
current) by enhancing the ratio between open and closed
time periods of this channel. This is shown schematically
in Fig. 1. But CF cells carrying the common CFTR mutant
affecting 70% of patients (loss of phenylalanine 508,
F508del, 1,479 amino acids; also known as DF508-CFTR)
do not respond to such stimuli. The defect in F508del-
CFTR opening is not due to a defective PKA and yet F508-
del CFTR only transiently ﬂickers to conduct ions after
cAMP elevation but then promptly closes, remaining
closed for prolonged periods. Brieﬂy, but detailed else-
where [16, 17] and in Fig. 1,
• When opened, wild-type CFTR will conduct chloride in
either an apical-to-inside cell or the reverse direction
(depending on the balance of membrane potential and
chloride concentration).
• ABC proteins typically have two nucleotide binding
domains (NBD1 and NBD2) which dimerise, ATP-
dependently, in a ‘69’ head to tail manner. A dimer is
required to open CFTR. Thereafter, ATP hydrolysis
drives a cycle of CFTR opening and closing by
complex means [17].
• After removal of its water shell, desiccated chloride
moves passively through the channel pore deep inside
CFTR in a direction driven by the direction of the
transmembrane electrochemical driving force ﬁeld
(felt only near the membrane lipids). The direction of
motion in to out or vice versa is set by the mostly
negative inside membrane potential (thus chloride and
other CFTR-permeant anions such as bicarbonate are
repelled from the cytosol) and may promote chloride
exit from a cell with an open CFTR. Why is the word
‘may’ used? Remarkably, after cAMP elevation and
PKA activation, this net chloride movement from the
cell (out of the apical membrane and into the bathing
milieu) can occur despite the fact that the intracellular
chloride is only *40 mM and chloride in the ﬂuid
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123bathing the outer leaﬂet of the apical membrane is 2.5
times higher at *100 mM. Thus controlling the
magnitude of a negative membrane potential is much
more important than concentration difference when
ions are moved. It follows that controlling a potassium
channel can control a chloride channel. If negative
enough, this voltage difference (PD) can drive chloride
‘uphill’ against concentration provided the PD is
‘negative enough’ (the terms hypo/hyperpolarised are
often used as shorthand to refer to transmembrane
voltage changes relative to baseline negativity; hyper =
more negative inside; reversal potential refers to the
balance point between concentration-drive counteract-
ing voltage: i.e. leading to zero net current through a
channel, Fig. 1). Similar considerations apply when
chloride moves into vesicles inside cells when a proton
moves in concert with chloride (not shown).
• Given that CK2 is now thought to control two other
ABC proteins, the cellular cholesterol level regulator
ABCA1 [18] and the multi-drug resistance drug efﬂux
pump MDR1/P-glycoprotein [19], it might be that CK2
is a latent factor in multiple ABC functions [20, 21].
For unknown reasons, CK2 inhibits ABCA1 (preserv-
ing cell cholesterol), whereas CK2 activity is
permissive for both MDR1 and CFTR. A cellular
imbalance of cholesterol accumulation has been pro-
posed in CF epithelial cells [22]. This notion of a wider
role for CK2 in ABC function is supported by a third
ABC protein recently reported to be controlled by CK2,
albeit one involved in translation at the ribosome [20].
Others have reported an inverse expression relationship
between CFTR and P-glycoprotein such that when one
is high the other is low in epithelia (and vice versa)
[21]. The (unknown) mechanisms of reciprocal expres-
sion are mirrored for the epithelial sodium channel
(ENaC) controlled by CFTR as described below.
In wild-type cells, CFTR controls ion channels
unrelated to CFTR
Non-CFTR channels are also disordered either after the
loss of F508 or the whole protein in CFTR null cells. These
other affected proteins include anion channels and one
cation channel that is highly selective for sodium ions. The
latter relationship has been summarised recently by Rotin
and co-workers [23]. This, the best studied interaction of
CFTR, which nevertheless is unexplained, is between some
forms of mutant CFTR and the consequent elevated ENaC
activity. When wild-type (but not F508del) CFTR is
expressed, ENaC is stabilised at the plasma membrane.
Normally ENaC is rapidly internalised in minutes (whereas
CFTR takes hours to recycle). Recently, the function and
trafﬁcking of this critical CFTR-regulated epithelial
sodium channel was also found to be controlled by CK2
[24]. Why should this be relevant?
Speculation
CK2 is reported to contain an allosteric site with a single
chloride ion in its structure that lies at a critical domain in
conjunction with ﬁxed water molecules and an inhibitor
moiety [25]. It has long been recognised that intracellular
chloride concentration regulates ENaC activity and that
extracellular chloride also controls CFTR [reviewed in 26,
27]. Further, we have reported that a bona ﬁde apical
membrane-associated CK2 target, nucleoside diphosphate
kinase (NDPK), a cancer-related protein manifests differ-
ential chloride/anion regulated histidine phosphorylation
[26, 27] but only when resident within its intact membrane
environment.
Discussion
What may be wrong in CF cells such that cancer can
occur?
From an apical membrane and cellular epithelial perspec-
tive, the need to maintain the ability to secrete and absorb
ﬂuid is crucial. For example, all epithelia are bathed by a
liquid elaborated by the epithelium itself and its underlying
submucosal glands [26, 27]. This function goes awry in CF
partly because the relative activities of CFTR and ENaC
become unbalanced (the glands block with mucus). Nor-
mally,thenegativeinsidemembranepotentialshouldtendto
drivechlorideoutbuttheverysamePDattractssodiuminthe
opposite direction—into the epithelial cell (external sodium
*130 mM,internal*10–20 mM,Fig. 2).Thecellexpends
as much as 40% of its energy maintaining an intracellular
sodium concentration below 20 mM and a CF cell may use
even more because sodium channels are overactive making
sodium extrusion even more energy utilising. Normally, the
apicalmembranecontainsENaC (incolon,lung,sweat duct,
etc.) and these channels are subject to tight multi-faceted
regulation which changes differentially when CFTR is
present or mutant. In the absence of CFTR at the apical
membrane, ENaC subunits are subject to phosphorylation,
ubiquitination, proteolysis and endocytosis keeping its res-
idence time very short [24]. All or some of these post-
translational modiﬁers change when CFTR is present. They
change once again when CFTR is mutant. Perhaps mutant
CFTR has an ENaC that is resident for too long. Critically,
ENaC rapidly disappears from the plasma membrane by
clathrin-mediated endocytosis but this retrieval of surface
exposed apical ENaC is inhibited by the presence of CFTR
Mol Cell Biochem (2008) 316:169–175 173
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of CK2 (which binds both ENaC and CFTR, Fig. 2)i n
coating and uncoating of such clathrin bearing vesicles by a
selective interaction only with inositol lipids of certain di-
phosphate containing lipid classes. CK2 is abundant Xeno-
pus oocytes and yet, strikingly, Kunzelmann and colleagues
[24] ﬁnd that CK2 is not detectable by immunoﬂuorescence
in the oocyte membrane when no ENaC is present. Yet
further, when ENaC is expressed, CK2a is now easily found
intheoocytemembrane.Conversely,CK2isundetectablein
the oocyte membrane when a mutant ENaC is expressed
devoidofitstworecognisedandfunctionallyimportantCK2
phosphorylation sites [24]. This suggests that CK2 is carried
by the ENaC to the membrane. In that paper [24] it is also
reported that the consensus sites of CK2 phosphorylation
of ENaC lie close to its known sites important for the
interaction of two of its subunits with an E3 ubiquitin ligase
(Nedd4-2) that normally degrades the protein. The model is
shown in Fig. 2. Namely, CK2-dependent phosphorylation
of the cytoplasmic loops of the channel prevented access to
ubiquitination and thereby delayed its internalisation. Our
recent data on CK2 and CFTR also support a model of car-
riage of CK2a to the membrane by other proteins as has
recentlybeenproposedforthekinasescaffoldofRAS(KSR)
[29]. With respect to Ras/KSR, the assembly of this scaffold
(that proximates RAF MEK and ERK) is also CK2 depen-
dent[29]andonce again,CK2iscarriedtothemembraneon
cytosolic KSR after cell stimulation.
Thus I propose that CK2 can be ‘carried’ to many pro-
cesses in membranes and is permissive (or inhibitory)
towards them, presumably after phosphorylation of either
itself, its target or both. The mechanisms involved form the
focus of our current work and we believe that the future is
bright with anticipation that the twin enigmas of excess
childhood/young adult CF cancer and CK2 biology may
actually provide insight into a common theme, each
informing the other. It has always been my belief that
detailed study of CF will tell us more about other processes
[30, 31] that overlap with CF, and CF-related cancer seems
a good model to study, particularly with respect to CK2
and the relationship between the fetal and adult gut. The
approach taken by Edelman and Balch [30, 31] represents
the future. They posit that CFTR is a hub of interactions in
an unknown pathway(s). In this view CFTR, currently
proposed to have only a channel function, may have an
alter ego. This review speculates that the enigmatic CK2 on
the half century of its discovery can interact with CFTR.
This interaction is such that CK2 is controlled differently
by CFTR when F508 is deleted [16]. Therefore, this CFTR
region, which is accessible on the periphery of the ﬁrst
nucleotide binding domain, controls a cancer-inducing
kinase with over 300 reported targets in a CF disease rel-
evant manner. We should not be surprised because after all,
in terms of the ‘investigational age’ of CFTR, it is a mere
novice, yet to reach its twentieth year in the human
consciousness.
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Ubiquitination that normally
removes this sodium channel
from the cell membrane cannot
do so when CK2 prevents the
ubiqitin ligase E3 from acting
on its normal binding sites
located on the regulatory
subunits (not shown in detail)
because the channel is now
phosphorylated close by (see
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relationship between CFTR and
ENaC remains unknown but
both are in the same apical
epithelial membrane and are
separately regulated by the same
kinase (CK2) and both are
controlled by feedback from ion
concentrations such as chloride
and sodium inside the cell (not
shown)
174 Mol Cell Biochem (2008) 316:169–175
123Acknowledgements The author’s laboratory is supported by the
Wellcome Trust and Cystic Fibrosis Trust. The views expressed are
his own. The author wishes to thank Dr Hongyu Li (University of
Bristol) for help with the ﬁgures.
References
1. Suh KS, Yuspa SH (2005) Intracellular chloride channels: critical
mediators of cell viability and potential targets for cancer
therapy. Curr Pharm Des 11:2753–2764. doi:10.2174/
1381612054546806
2. Kunzelmann K (2005) Ion channels and cancer. J Membr Biol
205:159–173. doi:10.1007/s00232-005-0781-4
3. Spitzner M, Ousingsawat J, Scheidt K, Kunzelmann K, Schreiber
R (2007) Voltage-gated K+ channels support proliferation of
colonic carcinoma cells. FASEB J 21:35–44. doi:10.1096/fj.06-
6200com
4. Lee EL, Shimizu T, Ise T et al (2007) Impaired activity of vol-
ume-sensitive Cl
- channel is involved in cisplatin resistance of
cancer cells. J Cell Physiol 211:513–521. doi:10.1002/jcp. 20961
5. Va ´zquez E, Nobles M, Valverde MA (2001) Defective regulatory
volume decrease in human cystic ﬁbrosis tracheal cells because
of altered regulation of intermediate conductance Ca
2+-depen-
dent potassium channels. Proc Natl Acad Sci USA 98:5329–
5334. doi:10.1073/pnas.091096498
6. Nouri-Sorkhabi MH, Chapman BE, O’Loughlin EV, Li Z, Kuchel
PW, Gaskin KJ (2005) NMR measurements of the diffusional
permeability of water in cultured colonic epithelial cancer cells.
Cell Biol Int 29:441–448. doi:10.1016/j.cellbi.2005.01.006
7. Monastyrskaya K, Tschumi F, Babiychuck EB, Stroka D, Drae-
ger A (2008) Annexins sense intracellular pH changes during
hypoxia. Biochem J 409:65–75. doi:10.1042/BJ20071116
8. Borthwick LA, Mcgaw J, Conner G et al (2007) The formation of
the cAMP/protein kinase A-dependent annexin 2-S100A10
complex with cystic ﬁbrosis conductance regulator protein
(CFTR) regulates CFTR channel function. Mol Biol Cell 9:3388–
3397. doi:10.1091/mbc.E07-02-0126
9. Walters S, Mehta A (2007) Epidemiology of cystic ﬁbrosis. In:
Hodson M, Geddes D, Bush A (eds) Cystic ﬁbrosis, 3rd edn.
Hodder Arnold, London
10. Trezise AEO (2007) Exquisite and multilevel regulation of CFTR
expression. In: Bush et al (eds) Cystic ﬁbrosis in the 21st century,
vol 34, Prog Respir Res. Karger, Basel, pp 11–20
11. Decherf G, Bouyer G, Ege ´e S, Thomas SLY (2007) Chloride
channels in normal and cystic ﬁbrosis human erythrocyte mem-
brane. Blood Cells Mol Dis 39:24–34. doi:10.1016/j.bcmd.2007.
02.014
12. Ibele AR, Koplin SA, Bruce L, Slaughenhoupt JV, Kryger AF,
Lund DP (2007) Colonic adenocarcinoma in a 13-year-old with
cystic ﬁbrosis. J Ped Surg 42:1–3
13. Marcorelles P, Tristan M, Gillet D, Lagarde N, Ferec C (2007)
Evolution of CFTR protein distribution in lung tissue from nor-
mal and CF human fetuses. Pediatr Pulmonol 42:1032–1040. doi:
10.1002/ppul.20690
14. Gallagher AM, Gottlieb RA (2001) Proliferation, not apoptosis,
alters epithelial cell migration in small intestine of CFTR null
mice. Am J Physiol 281:G681–G687
15. Umar S, Scott J, Sellin JH, Dubinsky WP, Morris AP (2000)
Murine colonic mucosa hyperproliferation. I. Elevated CFTR
expression and enhanced cAMP-dependent chloride secretion.
Am J Physiol 278:G753–G764
16. Pagano M, Arrigoni G, Marin O (2008) Modulation of protein
kinase CK2 activity by fragments of CFTR encompassing F508
may reﬂect functional links with cystic ﬁbrosis pathogenesis.
Biochem (in press)
17. Csanady L, Nairn AC, Gadsby DC (2006) Thermodynamics of
CFTR channel gating: a spreading conformational change initi-
ates an irreversible gating cycle. J Gen Physiol 128:523–533. doi:
10.1085/jgp. 200609558
18. Stein Roosbeek S, Frank Peelman F, Annick Verhee A et al
(2004) Phosphorylation by protein kinase CK2 modulates the
activity of the ATP binding cassette A1 transporter. J Biol Chem
279:37779–37788. doi:10.1074/jbc.M401821200
19. Di Maira G, Brustolon F, Bertacchini J et al (2007) Pharmaco-
logical inhibition of protein kinase CK2 reverts the multidrug
resistance phenotype of a CEM cell line characterized by high
CK2 level. Oncogene 26:6915–6926. doi:10.1038/sj.onc.1210495
20. Paytubi S, Morrice NA, Boudeau J, Proud CJ (2008) The N-
terminal region of ABC50 interacts with eukaryotic initiation
factor eIF2 and is a target for regulatory phosphorylation by CK2.
Biochem J 409:223–231. doi:10.1042/BJ20070811
21. Maitra R, Hamilton J (2005) Arsenite regulates cystic ﬁbrosis
transmembrane conductance regulator and P-glycoprotein: evi-
dence of pathway independence. Cell Physiol Biochem 16:1–3.
doi:10.1159/000087737
22. Jiang D, Fang D, Kelley TJ, Burgess JD (2008) Electrochemical
analysis of cell plasma membrane cholesterol at the airway sur-
face of mouse trachea. Anal Chem 80:1235–1239. doi:10.1021/
ac7019909
23. Lu C, Jiang C, Pribanic S, Rotin D (2007) CFTR stabilizes ENaC
at the plasma membrane. J Cyst Fibros 6:419–422. doi:10.1016/j.
jcf.2007.03.001
24. Bachhuber TA, Almaca J, Aldehini J et al (2008) Regulation of
the Epithelial Na
+ channel by protein kinase CK2. J Biol Chem
283:13225–13232
25. Raaf J, Brunstein E, Issinger OG, Nieﬁnd K (2007) The CK2a/
CK2b interface of human protein kinase CK2 harbors a binding
pocket for small molecules. Chem Biol 15:111–117. doi:
10.1016/j.chembiol.2007.12.012
26. Mehta A (2007) The cystic ﬁbrosis transmembrane recruiter the
alter ego of CFTR as a multi-kinase anchor. Pﬂugers Arch
455:215–221. doi:10.1007/s00424-007-0290-7
27. Mehta A (2005) CFTR: more than just a chloride channel. Pediatr
Pulmonol 39:292–298. doi:10.1002/ppul.20147
28. Korolchuk VI, Cozier G, Banting G (2005) Regulation of CK2
activity by phosphatidylinositol phosphates. J Biol Chem
280:40796–40801. doi:10.1074/jbc.M508988200
29. Ritt CD, Zhou M, Conrads T et al (2007) CK2 is a component of
the KSR1 scaffold complex that contributes to Raf kinase acti-
vation. Curr Biol 17(2):179–184. doi:10.1016/j.cub.2006.11.061
30. Ollero M, Brouillard F, Edelman A (2006) Cystic ﬁbrosis enters
the proteomics scene: new answers to old questions. Proteomics
6(14):4084–4099. doi:10.1002/pmic.200600028
31. Moyer BD, Balch WE (2001) A new frontier in pharmacology:
the endoplasmic reticulum as a regulated export pathway in
health and disease. Expert Opin Ther Targets 5(2):165–176
Mol Cell Biochem (2008) 316:169–175 175
123